We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRSO icon
12776
CALL
Peraso
PRSO
$10.2M
$99K ﹤0.01%
+498
New +$106K
SIEB icon
12777
PUT
Siebert Financial
SIEB
$78.9M
$99K ﹤0.01%
29,600
-12,200
-29% -$48.2K
SMMT icon
12778
CALL
Summit Therapeutics
SMMT
$10.6B
$99K ﹤0.01%
19,800
+7,800
+65% +$56K
STXS icon
12779
PUT
Stereotaxis
STXS
$138M
$99K ﹤0.01%
18,400
+3,100
+20% +$23.4K
TCRX icon
12780
TScan Therapeutics
TCRX
$52.8M
$99K ﹤0.01%
+11,922
New +$111K
YRD
12781
Yiren Digital
YRD
$104M
$99K ﹤0.01%
32,997
+17,100
+108% +$67.5K
TCON
12782
PUT
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$99K ﹤0.01%
1,285
+415
+48% +$35.1K
DSKE
12783
PUT
DELISTED
Daseke, Inc. Common Stock
DSKE
$99K ﹤0.01%
10,800
-19,800
-65% -$165K
GOEV
12784
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$99K ﹤0.01%
28
-514
-95% -$1.83M
CTG
12785
DELISTED
Computer Task Group, Inc.
CTG
$99K ﹤0.01%
12,327
-17,321
-58% -$152K
USX
12786
PUT
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$99K ﹤0.01%
11,500
-13,000
-53% -$113K
ZVO
12787
PUT
DELISTED
Zovio Inc. Common Stock
ZVO
$99K ﹤0.01%
41,300
+14,500
+54% +$35.8K
KLDO
12788
CALL
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$99K ﹤0.01%
18,100
+300
+2% +$1.86K
ODT
12789
PUT
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$99K ﹤0.01%
33,900
+6,200
+22% +$20.6K
ATNM icon
12790
Actinium Pharmaceuticals
ATNM
$32.6M
$98K ﹤0.01%
+11,001
New +$76.5K
FRSX
12791
PUT
Foresight Autonomous Holdings
FRSX
$3.87M
$98K ﹤0.01%
249
-148
-37% -$62.5K
JOB icon
12792
GEE Group
JOB
$27M
$98K ﹤0.01%
211,081
+162,794
+337% +$81.3K
LFCR icon
12793
PUT
Lifecore Biomedical
LFCR
$179M
$98K ﹤0.01%
10,600
-12,300
-54% -$134K
QUIK icon
12794
CALL
QuickLogic
QUIK
$234M
$98K ﹤0.01%
18,200
-500
-3% -$2.84K
SIGA icon
12795
SIGA Technologies
SIGA
$216M
$98K ﹤0.01%
+13,323
New +$85.4K
SLE icon
12796
Super League Enterprise
SLE
$3.65M
$98K ﹤0.01%
+3
New +$118K
URG
12797
Ur-Energy
URG
$537M
$98K ﹤0.01%
57,359
+8,365
+17% +$11.2K
WVE icon
12798
PUT
Wave Life Sciences
WVE
$1.07B
$98K ﹤0.01%
19,900
-3,400
-15% -$20.6K
CORR
12799
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$98K ﹤0.01%
22,031
-8,805
-29% -$44.6K
OSTRW
12800
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$98K ﹤0.01%
181,323
– –
510 511
512
513 514

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.